Skip to main content
NIH funding notice PA-17-155

Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)

Closed on May 7, 2020.

Posted
February 8, 2017
Close date
May 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $987,125 in first-year total cost, median $493,563.

Most frequent study sections

  1. Molecular Neuropharmacology and Signaling Study Section[MNPS]2

Most frequent institutions

  1. SCRIPPS FLORIDA1
  2. UNIVERSITY OF MARYLAND BALTIMORE1
Competing awards under PA-17-155 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Regulation of Striatal GPCR Signaling2R01DA036596-06MARTEMYANOV, KIRILL A.SCRIPPS FLORIDA, FL$552,841MNPS
2019Ventral pallidum molecular mediators in cocaine addiction1R01DA047843-01LOBO, MARY KAYUNIVERSITY OF MARYLAND BALTIMORE, MD$434,284MNPS

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.